MASSACHUSETTS FINANCIAL SERVICES CO 13D and 13G filings for Maravai LifeSciences Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-11-07 11:09 am Sale |
2023-11-07 | 13G | Maravai LifeSciences Holdings, Inc. MRVI |
MASSACHUSETTS FINANCIAL SERVICES CO | 6,058,247 4.600% |
-6,989,713 (-53.57%) |
Filing |
| 2023-02-08 4:07 pm Sale |
2023-02-08 | 13G | Maravai LifeSciences Holdings, Inc. MRVI |
MASSACHUSETTS FINANCIAL SERVICES CO | 13,047,960 9.900% |
-884,724 (-6.35%) |
Filing |
| 2022-09-06 4:00 pm Unchanged |
2022-09-06 | 13G | Maravai LifeSciences Holdings, Inc. MRVI |
MASSACHUSETTS FINANCIAL SERVICES CO | 13,932,684 10.600% |
0 (Unchanged) |
Filing |
| 2022-09-06 2:37 pm Purchase |
2022-09-06 | 13G | Maravai LifeSciences Holdings, Inc. MRVI |
MASSACHUSETTS FINANCIAL SERVICES CO | 13,932,684 10.600% |
5,929,663 (+74.09%) |
Filing |
| 2022-02-02 12:46 pm Purchase |
2022-02-02 | 13G | Maravai LifeSciences Holdings, Inc. MRVI |
MASSACHUSETTS FINANCIAL SERVICES CO | 8,003,021 6.100% |
8,003,021 (New Position) |
Filing |